단독보도: 한국임상 결과

실제 뉴스가 아닌 사용자가 만든 가상의 이야기입니다. Wolfstreet ass reported that COVID-19 treatment related trials are on-going. Among the studies, oral drug formulation researches attracted people's interests. In south Korea, Shipoong Pharm Co., Ltd. conducted phase II clinical study to prove the superiority of Pyramox compared to the placebo by assessing the turnover rate of RT-PCR into being negative in patients with mild to severe COVID19 infection. However, there are some anticipation that the result will be disappointing since Dr.Shin suggested that the method assessing primary endpoint should be highly changed in all of sudden. However the chances are that Korean regulatory agency, MFDS might not accept the concept.